CLINICAL_TRIALS
trial_result
· 2017-03-20
Clinical Trial Update: A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD [Phase 3]
Summary
Pfizer's Phase 3 study of DVS SR in children and adolescents with Major Depressive Disorder has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-03-20